• BeiGene Purchases New U.S. Manufacturing and Clinical R&D Center AmericanPharmaceuticalReview
    December 02, 2021
    BeiGene, Ltd., a global biotechnology company focused on developing and commercializing innovative cancer medicines worldwide, announced today that it has purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, N.J. to house a new...
PharmaSources Customer Service